Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration

Pain Uterus Clinical Trial

Official title:
Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration: A Randomized Controlled Trial

Status Completed

Clinical Trial Summary

Intranasal fentanyl has been found to be safe and effective in the reduction of pain among pediatric and adult populations. The investigators hypothesize that patients who receive 100 mcg of intranasal fentanyl for pain control before first-trimester uterine aspiration will report lower pain scores than those who receive placebo. The investigators will test this hypothesis using a randomized, double-blind, placebo-controlled trial comparing pain reported during uterine aspiration between patients who receive either intranasal fentanyl or intranasal saline prior to the procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pain Uterus

Clinical Trial Details

NCT number	NCT03057041
Study type	Interventional
Source	University of Hawaii
Contact
Status	Completed
Phase	N/A
Start date	March 23, 2017
Completion date	May 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03636451` - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o	Phase 3
Completed	`NCT03279666` - Biopsy Size and Pain Perception During Colposcopic Biopsy	N/A
Completed	`NCT03314792` - Effects of Tapentadol Versus Oxycodone After Hysterectomy.	Phase 4
Recruiting	`NCT03382743` - Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy	Phase 2/Phase 3